Arnaud L - Search Results

1

Curve matching to predict growth in patients receiving growth hormone therapy: An interpretable & explainable method.

van Dommelen P, Arnaud L, Koledova E. van Dommelen P, et al. Among authors: arnaud l. Front Endocrinol (Lausanne). 2022 Oct 5;13:999077. doi: 10.3389/fendo.2022.999077. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277722 Free PMC article.

2

High Engagement of Patients Monitored by a Digital Health Ecosystem Indicates Significant Improvements of Key r-hGH Treatment Metrics.

Spataru A, Quarteroni S, Arnaud L, van Dommelen P, Koledova E, Le Masne Q. Spataru A, et al. Among authors: arnaud l. Stud Health Technol Inform. 2021 May 27;281:829-833. doi: 10.3233/SHTI210295. Stud Health Technol Inform. 2021. PMID: 34042790

3

Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.

Assefi A, van Dommelen P, Arnaud L, Otero C, Fernandez-Luque L, Koledova E, Calliari LE. Assefi A, et al. Among authors: arnaud l. JMIR Mhealth Uhealth. 2022 Jan 20;10(1):e32626. doi: 10.2196/32626. JMIR Mhealth Uhealth. 2022. PMID: 35049518 Free PMC article.

4

Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.

Spataru A, van Dommelen P, Arnaud L, Le Masne Q, Quarteroni S, Koledova E. Spataru A, et al. Among authors: arnaud l. BMC Med Inform Decis Mak. 2022 Jul 6;22(1):179. doi: 10.1186/s12911-022-01918-2. BMC Med Inform Decis Mak. 2022. PMID: 35794586 Free PMC article.

5

Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis.

Tornincasa V, Dixon D, Le Masne Q, Martin B, Arnaud L, van Dommelen P, Koledova E. Tornincasa V, et al. Among authors: arnaud l. Front Endocrinol (Lausanne). 2022 Jun 30;13:882192. doi: 10.3389/fendo.2022.882192. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846336 Free PMC article.

6

The growzen™ buddy smartphone app to improve adherence in patients receiving recombinant human growth hormone therapy: a retrospective observational study in Argentina.

van Dommelen P, Arnaud L, Assefi AR, Crespo ML, Debicki M, Michelis F, Koledova E. van Dommelen P, et al. Among authors: arnaud l. Front Endocrinol (Lausanne). 2024 Jul 2;15:1372716. doi: 10.3389/fendo.2024.1372716. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39015178 Free PMC article.

7

Preferences for Injection Device Settings and the Association with Adherence to Growth Hormone Treatment in Patient with Growth Disorders.

van Dommelen P, Rivera-Romero O, Arnaud L, Zucchiatti C, Koledova E. van Dommelen P, et al. Among authors: arnaud l. Stud Health Technol Inform. 2024 Aug 22;316:38-42. doi: 10.3233/SHTI240339. Stud Health Technol Inform. 2024. PMID: 39176668

8

Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years.

Piras F, Arnaud L, Henninger E, Keiser M, Seitzinger A, Jack D, Le Masne Q. Piras F, et al. Among authors: arnaud l. Expert Opin Drug Deliv. 2023 Jun;20(6):863-870. doi: 10.1080/17425247.2023.2221432. Epub 2023 Jun 7. Expert Opin Drug Deliv. 2023. PMID: 37273189 Free article.

9

Neurological manifestations in patients with VEXAS syndrome.

Bert-Marcaz C, Fortanier É, Briantais A, Faucher B, Bourguiba R, Swiader L, Schleinitz N, Corazza G, Jean R, Bigot A, Marianetti-Guingel P, Kostine M, Outh R, Dieudonné Y, Lazaro E, Vial G, Palat S, Frachet S, De Almeida Chaves S, Vinzio S, Sacré K, Robert M, Comont T, Dion J, Girardie P, Lacombe V, Langlois V, Jachiet V, Decker P, Moulinet T, Grosleron S, Broner J, Guilpain P, Samson M, Terrier B, Georgin-Lavialle S, Attarian S, Mekinian A, Delmont E, Ebbo M; FRENVEX; MINHEMON; FILNEMUS. Bert-Marcaz C, et al. J Neurol. 2025 Feb 1;272(2):181. doi: 10.1007/s00415-025-12902-x. J Neurol. 2025. PMID: 39891740

10

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients.

Cambon A, Guervilly C, Delteil C, Potere N, Bachelier R, Tellier E, Abdili E, Leprince M, Giani M, Polidoro I, Albanese V, Ferrante P, Coffin L, Schiffrin M, Arnaud L, Lacroix R, Roque S, Forel JM, Hraiech S, Daniel L, Papazian L, Dignat-George F, Kaplanski G. Cambon A, et al. Among authors: arnaud l. Front Immunol. 2025 Jan 15;15:1493306. doi: 10.3389/fimmu.2024.1493306. eCollection 2024. Front Immunol. 2025. PMID: 39882243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters